The study was approved by an Institutional Review Board (IRB) of the Sheba Medical Center. Helsinki approval number: SMC-8228-21. Individuals included at this study were tested charge-free as part of the Israeli testing and surveillance program. Patient consent was waived, as this is a retrospective analysis using data which was collected as part of the national testing and surveillance program. The investigators did not have access to de-anonymized information.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.